Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-24

Clinical Trial Update: Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Candida eradication and serum cidal activity of echinocandins in patients with candidemia; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cancidas (caspofungin)
  • Eraxis (anidulafungin)
  • Mycamine (Micafungin)

Snippet

Sponsor: Gary E. Stein, Pharm.D. | Conditions: Candidemia | Phase 4 | Status: COMPLETED | Results posted: 2012-02-24